BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18664273)

  • 1. Divergent mechanisms underlie Smad4-mediated positive regulation of the three genes encoding the basement membrane component laminin-332 (laminin-5).
    Zboralski D; Böckmann M; Zapatka M; Hoppe S; Schöneck A; Hahn SA; Schmiegel W; Schwarte-Waldhoff I
    BMC Cancer; 2008 Jul; 8():215. PubMed ID: 18664273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncoupled responses of Smad4-deficient cancer cells to TNFalpha result in secretion of monomeric laminin-gamma2.
    Zboralski D; Warscheid B; Klein-Scory S; Malas MB; Becker H; Böckmann M; Meyer HE; Schmiegel W; Simon-Assmann P; Schwarte-Waldhoff I
    Mol Cancer; 2010 Mar; 9(1):65. PubMed ID: 20307265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basement membrane component laminin-5 is a target of the tumor suppressor Smad4.
    Zapatka M; Zboralski D; Radacz Y; Böckmann M; Arnold C; Schöneck A; Hoppe S; Tannapfel A; Schmiegel W; Simon-Assmann P; Schwarte-Waldhoff I
    Oncogene; 2007 Mar; 26(10):1417-27. PubMed ID: 16953227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Converging signals synergistically activate the LAMC2 promoter and lead to accumulation of the laminin gamma 2 chain in human colon carcinoma cells.
    Olsen J; Kirkeby LT; Brorsson MM; Dabelsteen S; Troelsen JT; Bordoy R; Fenger K; Larsson LI; Simon-Assmann P
    Biochem J; 2003 Apr; 371(Pt 1):211-21. PubMed ID: 12519076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic cooperation between Sp1 and Smad3/Smad4 mediates transforming growth factor beta1 stimulation of alpha 2(I)-collagen (COL1A2) transcription.
    Zhang W; Ou J; Inagaki Y; Greenwel P; Ramirez F
    J Biol Chem; 2000 Dec; 275(50):39237-45. PubMed ID: 11007770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential cytokine modulation of the genes LAMA3, LAMB3, and LAMC2, encoding the constitutive polypeptides, alpha 3, beta 3, and gamma 2, of human laminin 5 in epidermal keratinocytes.
    Korang K; Christiano AM; Uitto J; Mauviel A
    FEBS Lett; 1995 Jul; 368(3):556-8. PubMed ID: 7635220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma.
    Sathyanarayana UG; Padar A; Huang CX; Suzuki M; Shigematsu H; Bekele BN; Gazdar AF
    Clin Cancer Res; 2003 Dec; 9(17):6389-94. PubMed ID: 14695139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of activator protein 1 complexes in the epithelium-specific activation of the laminin gamma2-chain gene promoter by hepatocyte growth factor (scatter factor).
    Olsen J; Lefebvre O; Fritsch C; Troelsen JT; Orian-Rousseau V; Kedinger M; Simon-Assmann P
    Biochem J; 2000 Apr; 347(Pt 2):407-17. PubMed ID: 10749670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells.
    Peng B; Fleming JB; Breslin T; Grau AM; Fojioka S; Abbruzzese JL; Evans DB; Ayers D; Wathen K; Wu T; Robertson KD; Chiao PJ
    Clin Cancer Res; 2002 Nov; 8(11):3628-38. PubMed ID: 12429655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant promoter methylation of laminin-5-encoding genes in prostate cancers and its relationship to clinicopathological features.
    Sathyanarayana UG; Padar A; Suzuki M; Maruyama R; Shigematsu H; Hsieh JT; Frenkel EP; Gazdar AF
    Clin Cancer Res; 2003 Dec; 9(17):6395-400. PubMed ID: 14695140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant up-regulation of LAMB3 and LAMC2 by promoter demethylation in gastric cancer.
    Kwon OH; Park JL; Kim M; Kim JH; Lee HC; Kim HJ; Noh SM; Song KS; Yoo HS; Paik SG; Kim SY; Kim YS
    Biochem Biophys Res Commun; 2011 Mar; 406(4):539-45. PubMed ID: 21345334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-expression of laminin β3 and γ2 chains and epigenetic inactivation of laminin α3 chain in gastric cancer.
    Ii M; Yamamoto H; Taniguchi H; Adachi Y; Nakazawa M; Ohashi H; Tanuma T; Sukawa Y; Suzuki H; Sasaki S; Imai K; Shinomura Y
    Int J Oncol; 2011 Sep; 39(3):593-9. PubMed ID: 21617852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein.
    Yingling JM; Datto MB; Wong C; Frederick JP; Liberati NT; Wang XF
    Mol Cell Biol; 1997 Dec; 17(12):7019-28. PubMed ID: 9372933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional activation of mouse sst2 somatostatin receptor promoter by transforming growth factor-beta. Involvement of Smad4.
    Puente E; Saint-Laurent N; Torrisani J; Furet C; Schally AV; Vaysse N; Buscail L; Susini C
    J Biol Chem; 2001 Apr; 276(16):13461-8. PubMed ID: 11278805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative control of TRAIL-R1 signaling by transforming growth factor β1 in pancreatic tumor cells involves Smad-dependent down regulation of TRAIL-R1.
    Radke DI; Ungefroren H; Helm O; Voigt S; Alp G; Braun H; Hübner S; Dilchert J; Sebens S; Adam D; Kalthoff H; Trauzold A
    Cell Signal; 2016 Nov; 28(11):1652-62. PubMed ID: 27492861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-level inducible Smad4-reexpression in the cervical cancer cell line C4-II is associated with a gene expression profile that predicts a preferential role of Smad4 in extracellular matrix composition.
    Klein-Scory S; Zapatka M; Eilert-Micus C; Hoppe S; Schwarz E; Schmiegel W; Hahn SA; Schwarte-Waldhoff I
    BMC Cancer; 2007 Nov; 7():209. PubMed ID: 17997817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smad4 regulates claudin-1 expression in a transforming growth factor-beta-independent manner in colon cancer cells.
    Shiou SR; Singh AB; Moorthy K; Datta PK; Washington MK; Beauchamp RD; Dhawan P
    Cancer Res; 2007 Feb; 67(4):1571-9. PubMed ID: 17308096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smad4/DPC4-dependent regulation of biglycan gene expression by transforming growth factor-beta in pancreatic tumor cells.
    Chen WB; Lenschow W; Tiede K; Fischer JW; Kalthoff H; Ungefroren H
    J Biol Chem; 2002 Sep; 277(39):36118-28. PubMed ID: 12140283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SMAD4 gene promoter mutations in patients with thyroid tumors.
    Nikolic A; Ristanovic M; Zivaljevic V; Rankov AD; Radojkovic D; Paunovic I
    Exp Mol Pathol; 2015 Aug; 99(1):100-3. PubMed ID: 26079547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperative binding of Smad proteins to two adjacent DNA elements in the plasminogen activator inhibitor-1 promoter mediates transforming growth factor beta-induced smad-dependent transcriptional activation.
    Stroschein SL; Wang W; Luo K
    J Biol Chem; 1999 Apr; 274(14):9431-41. PubMed ID: 10092624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.